Kairos Pharma Ltd. (KAPA)
AMEX: KAPA
· Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Sep 05, 2025, 10:05 AM
4.52% (1D)
| Bid | 1.61 |
| Market Cap | 33.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -4.71M |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -5.77 |
| Forward PE | -3.92 |
| Analyst | Buy |
| Ask | 1.63 |
| Volume | 527,103 |
| Avg. Volume (20D) | 5,245,154 |
| Open | 1.58 |
| Previous Close | 1.55 |
| Day's Range | 1.58 - 1.68 |
| 52-Week Range | 0.40 - 4.00 |
| Beta | 2.36 |
About KAPA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KAPA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KAPA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+70.8%
Kairos Pharma shares are trading higher after the ...
Unlock content with
Pro Subscription
3 months ago
-23.47%
Kairos Pharma shares are trading lower. The company presented data on its GITR ligand agonist KROS101 at ASCO 2025.
